MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Huntington’s disease in the Republic of Tatarstan, epidemiological features

    S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)

    Objective: To evaluate the epidemiological features of Huntington's disease (HD) according to the Centre for Movement Disorders and Botulinum Therapy of Republic of Tatarstan (Centre…)…
  • 2017 International Congress

    Myths and Misconceptions Regarding Huntington’s Disease in Peru

    A. Vishnevetsky, M. Illanes-Manrique, M. Inca-Martinez, M. Cornejo-Olivas (Philadelphia, PA, USA)

    Objective: To explore the understanding and conceptualization of Huntington’s disease (HD) genetics and pathology among HD patients and family caregivers in Peru. Background: HD is…
  • 2017 International Congress

    Clinical and genetic characterization of Huntington’s disease in relation to the age and type of onset.

    L. Mendoza Vega, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. De-la-Cruz-Landero, N. Davila-Avila, K. Salinas-Barboza, S. Isais-Millan (Mexico City, Mexico)

    Objective: To describe the clinical features and CAG repeats in a large population of Mexican patients with Huntington's disease and its relation to the age…
  • 2017 International Congress

    Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder.

    E. Antelmi, V. Donadio, G. Plazzi, R. Liguori (Bologna, Italy)

    Objective: Here we tested if p-syn deposits can be detected with the same approach in patients affected with idiopathic RBD (iRBD), as an early histopathological…
  • 2017 International Congress

    Firing rate and proportion of subthalamic oscillatory neurons increase associated with more advanced Parkinson’s Disease

    P. Zhuang, M. Hallett, Y. Wen, Y. Zhang, J. Li, Y. Li (Beijing, China)

    Objective: To explore whether neuronal firing rate and proportion of oscillatory neuronal activity in the subthalamic nucleus (STN) is associated with severity in patients with…
  • 2017 International Congress

    Alpha-Synuclein knock-out mouse brain shows significant dysregulation of c-Fos expression

    M. Overhoff, J. Canet-Pons, D. Meierhofer, S. Gispert, G. Auburger (Frankfurt am Main, Germany)

    Objective: We aimed to understand the physiological function of alpha-synuclein (SNCA) for neuronal projections within the brain, particularly its effects on entire pathways and on…
  • 2017 International Congress

    Increased bilirubin levels in Parkinson’s disease from southern Spain.

    D. Macias Garcia, D. Macias Garcia, C. Mendez Barrio, S. Jesus, M.A. Labrador Espinosa, M. Bernal Escudero, L. Vargas Gonzalez, A. Adarmes Gomez, F. Carrillo, M. Carballo, P. Gómez-Garre, P. Mir (Seville, Spain)

    Objective: To evaluate serum bilirubin concentration in Parkinson’s disease (PD) compared to healthy controls (HC) and to investigate its associations with motor and non-motor features…
  • 2017 International Congress

    Catecholamines’ concentration ratio in plasma of early diagnosed treatment-naive patients with Parkinson disease

    Z. Zalyalova, D. Khasanova (Kazan, Russian Federation)

    Objective: To investigate the concentration of some catecholamines (dopamine, DOPA and DOPAC) in the blood plasma and their ratio to each other depending on sex, form and…
  • 2017 International Congress

    Intracortical plasticity is preserved in de novo Parkinson’s disease: a tSMS study.

    M. Dileone, V. Catanzaro, J. Obeso, G. Foffani (Mostoles, Spain)

    Objective: To test the intracortical plasticity of motor cortex in treatment-naïve (de novo) patients with Parkinson’s disease (PD), by means of transcranial static magnetic field…
  • 2017 International Congress

    The comparison of urine microvesicle reflecting gut microbiome between Parkinson’s disease and healthy control

    J. Park, S. Park, W. Jang, J.S. Kim, J. Yoon, E. Oh (Busan, Republic of Korea)

    Objective: The objective of this study to compare urine microvesicle between Parkinson’s disease(PD) and healthy controls Background: Recent researches showed that gut microbiome interact with central…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley